BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29693143)

  • 1. Loss of RUNX3 is significantly associated with advanced tumor grade and stage in endometrial cancers.
    Jeong D; Kim H; Ryu A; Sunwoo J; Choi SD; Nam GH; Jeon S
    Mol Med Rep; 2018 Jun; 17(6):8173-8179. PubMed ID: 29693143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent inactivation of RUNX3 in endometrial carcinoma.
    Yoshizaki T; Enomoto T; Fujita M; Ueda Y; Miyatake T; Fujiwara K; Miyake T; Kimura T; Yoshino K; Kimura T
    Gynecol Oncol; 2008 Sep; 110(3):439-44. PubMed ID: 18572225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of 5-aza-2'-deoxycytidine on growth and methylation of RUNX3 gene in human pancreatic cancer cell line MiaPaca2].
    Han X; Tan ZJ; Guo RD; Li ZJ; Wang YL
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):17-21. PubMed ID: 23648294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines.
    Zhang S; Wei L; Zhang A; Zhang L; Yu H
    OMICS; 2009 Aug; 13(4):307-11. PubMed ID: 19645591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
    Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
    Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.
    Lau QC; Raja E; Salto-Tellez M; Liu Q; Ito K; Inoue M; Putti TC; Loh M; Ko TK; Huang C; Bhalla KN; Zhu T; Ito Y; Sukumar S
    Cancer Res; 2006 Jul; 66(13):6512-20. PubMed ID: 16818622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Promoter methylation and expression of Runx3 gene in gastric cancer].
    Li LY; Li JK; Shen Y; Yu L; Zhang JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):379-82. PubMed ID: 18636364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
    Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
    J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
    Yan C; Kim YW; Ha YS; Kim IY; Kim YJ; Yun SJ; Moon SK; Bae SC; Kim WJ
    J Surg Oncol; 2012 Mar; 105(4):425-30. PubMed ID: 22311819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.
    Yanada M; Yaoi T; Shimada J; Sakakura C; Nishimura M; Ito K; Terauchi K; Nishiyama K; Itoh K; Fushiki S
    Oncol Rep; 2005 Oct; 14(4):817-22. PubMed ID: 16142337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
    Guo ZL; Chen K; Wang XQ; Hu W
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between the methylation status of Runx3 gene and positive expression of estrogen receptor in breast cancer].
    Yan Z; Gao S; Wu X; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):240-4. PubMed ID: 25975905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of transcriptional gene silencing and mechanism induced by shRNAs targeted to RUNX3 in vitro.
    Feng XZ; He XS; Zhuang YZ; Luo Q; Jiang JH; Yang S; Tang XF; Liu JL; Chen T
    World J Gastroenterol; 2008 May; 14(19):3006-14. PubMed ID: 18494051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX3 Methylation, Loss of RUNX3 Expression and Clinicopathologic Findings according to Helicobacter pylori CagA in Gastric Carcinoma.
    Na YJ; Shim KN; Joo YH; Kim SE; Jung HK; Jung SA; Cho MS
    Korean J Gastroenterol; 2015 Aug; 66(2):75-84. PubMed ID: 26289240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
    Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
    Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma.
    Dachrut S; Banthaisong S; Sripa M; Paeyao A; Ho C; Lee SA; Kosinski C; Patil MA; Zhang J; Chen X; Sripa B; Pairojkul C
    Asian Pac J Cancer Prev; 2009; 10(4):575-82. PubMed ID: 19827872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demethylation of RUNX3 by vincristine in colorectal adenocarcinoma cells.
    Moon JW; Lee SK; Lee JO; Kim JH; Kim N; Kim J; Kim HS; Park SH
    Anticancer Res; 2014 Jan; 34(1):133-40. PubMed ID: 24403453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
    Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
    Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.